India drugmaker stocks exception in Asian rout

Last Updated: Thursday, September 3, 2015, 19:37

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.

Dr Reddy's to market three Amgen drugs in India

Last Updated: Thursday, August 6, 2015, 12:57

Dr Reddy's Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.

Dr Reddy's shares gain over 5% on Q1 net jump

Last Updated: Thursday, July 30, 2015, 17:39

At the NSE, shares of the company rose by 5.4 percent to close at Rs 3,913.10.

DRL's net up 14% at Rs 626 crore; Russia a drag

Last Updated: Thursday, July 30, 2015, 14:45

The company had posted a net profit of Rs 550.39 crore for the corresponding quarter of the previous fiscal, Dr Reddy's Laboratories said in a BSE filing.

Dr Reddy's Laboratories working on 18 new drug applications

Last Updated: Sunday, June 21, 2015, 21:32

Drugmaker Dr Reddy's Laboratories Limited is working on 18 new drug applications, including the three NDAs it has already filed with the US Food and Drug Administration, and expects 2 more drugs to go for approvals before 2018.

Dr Reddy's launches hair growth supplement

Last Updated: Friday, June 19, 2015, 21:08

The supplement provides key nutrients needed for maintaining healthy hair and according to the company, has a unique formula including grape seed extract containing potent antioxidants.

Dr Reddy's Lab completes acquisition of UCB's select brands

Last Updated: Friday, June 19, 2015, 13:23

Dr Reddy's has said the acquired UCB portfolio would accelerate its presence in the high growth areas of dermatology, respiratory and pediatrics, with market leading brands such as Atarax, Nootropil, Zyrtec, Xyzal and Xyzal M.

AstraZeneca, Dr Reddy's ink diabetes drug distribution pact

Last Updated: Friday, May 29, 2015, 19:32

AstraZeneca Pharma India and Dr Reddy's Laboratories on Friday entered into a distribution agreement for two drugs -- Riax and Riax-M -- used for treatment of diabetes in India.

Dr Reddy's scrip gains nearly 4% on launching drug

Last Updated: Monday, May 18, 2015, 20:43

Shares of Dr Reddy's Laboratories Monday rose by nearly 4 percent after the company launched Somazina, a drug used for treating those who have suffered stroke, in India.

Dr Reddy's Lab to enter Japanese market through a partner

Last Updated: Tuesday, May 12, 2015, 19:37

Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.

Dr Reddy's Q4 net rises 8% to Rs 519 crore

Last Updated: Tuesday, May 12, 2015, 16:02

The company had posted a net profit of Rs 481.60 crore for the corresponding period of previous fiscal, it said in a filing to the BSE.

Dr Reddy's sees India sales growing 20% on new product launches

Last Updated: Friday, April 10, 2015, 11:06

Dr Reddy`s Laboratories Ltd, India`s second-largest drugmaker, expects domestic sales to grow nearly 20 percent this financial year, helped by the launch of nearly two dozen products, a senior executive said.